Agile Therapeutics (AGRX) Fails to deliver data

Key failure to deliver metrics for Agile Therapeutics :

• Last SEC data release: 2024-10-31
• Last 15 days FTD volume: N/A
• Last 3 months FTD volume: N/A
• Last year FTD volume: N/A

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Agile Therapeutics (AGRX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Agile Therapeutics (AGRX) - since 2023

Agile Therapeutics (AGRX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
TherapeuticsMD TXMD	A$0.03 M	A$0.22 M	🇺🇸 USA
Antares Pharma ATRS	N/A	A$5.91 M	🇺🇸 USA
Johnson & Johnson JNJ	A$70.18 M	A$0.32 B	🇺🇸 USA
Merck MRK	A$14.45 M	A$88.44 M	🇺🇸 USA
Pfizer PFE	A$50.21 M	A$0.38 B	🇺🇸 USA